samsung_biologics_plant_2
The spin-off is meant to improve operational focus and address concerns raised by its CDMO customers about potential conflicts of interest.

Be Sure To Read

enzenehero
With a record number of FDA biosimilar approvals in 2024, CMOs specializing in biologics can expect to see higher biosimilar volumes, according to GlobalData.
rochebldg
The company warned that if the executive order goes into effect, Roche’s ability to invest $50 billion in its U.S. R&D and manufacturing sites will be in question.
bayer_cross_in_leverkusen_at_nightdefault
CEO Bill Anderson said that the company has “considerable” production capabilities in both the U.S. and Europe but has no immediate plans to shift them.
takedabldg
CEO Christophe Weber said that the investment is not a new strategy and reflects the position of the U.S. as the world’s leading market for biopharma innovation.
shutterstock_1718136397
Combined, the company projects these efforts will generate $43 billion in economic impact over the next five years.
shutterstock_2194452323
The announcement comes after President Trump signed an executive order aimed at expediting the approval process for domestic pharmaceutical manufacturing facilities.

Exclusives

Pharma events calendar

Keep track of in-person industry events.


Articles

The latest content from industry thought leaders.


Editors' (re)View

Weekly takes on things going on in the pharma world.

dreamstime_xxl_20143044
dreamstime_xxl_20143044
Contract development and manufacturing organizations (CDMOs) are more critical than ever to the biopharmaceutical industry, providing essential outsourcing services to customers...
pharma_mood_1540x800_1
Explore how real-time TOC sensors are transforming pharmaceutical water systems by delivering continuous monitoring of organic contaminants, ensuring compliance and safety. With...
pharma_manuf_hero_1540x800
Blending and tableting create hazardous dusts. Learn how dust collector filters reduce exposure—download our eBook about media that is best for each dust type.
mt_4key_1450x800
Pharmaceutical manufacturing hinges on the production of purified water that meets strict pharmacopeia regulations. To ensure consistent water quality, real-time monitoring is...
mt_1540x800_5_ways
Take corrective action before a system goes out of specification, ensuring that your processes remain streamlined and compliant. With continuous insights at your fingertips, you...
mt_pharma_waters_1540x800
Regulations in the pharmaceutical industry are constantly increasing— and navigating them doesn’t have to be overwhelming. Discover a real-world example using continuous TOC monitoring...

With a focus on CGT manufacturing, BioForge will be operational by 2027.
Building on its manufacturing legacy, Pittsburgh is now headed in a new direction — from steel to science

shutterstock_2079390133
The future of non-clinical research may depend on integrating VCGs for a more humane and efficient approach.
A look at consequential drug approvals and rejections from this year
Michael Annino/Shutterstock AI
With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon
A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding

shutterstock_2467268685
Adhering to a tried-and-true set of best practices during the PPQ stage can prevent a drug approval from stalling out on the final lap.

Michael Annino | Shutterstock-AI
pm2409_hero854x480_2
Pharmacologic approaches to treating aging are edging closer to maturity
Michael Annino/Shutterstock AI
pm2409_hero854x480_2coverstory
New treatments offer the promise of tackling age-related disease multimorbidity
Michael Annino/Shutterstock AI
pm2409_hero854x480_coverstory
Novel therapeutic approaches to aging are creating a healthspan market with staying power

Slideshows

A robust contamination control strategy isn't merely a guideline, it's a necessity
Microsoft Teams Image (7)
Quick answers to all your pharma manufacturing questions
Shutterstock 749369605
13 pharma scaries….and solutions that offer reprieve